Exagen (XGN) Short Interest Ratio & Short Volume → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free XGN Stock Alerts $1.37 -0.03 (-2.14%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Exagen Short Interest DataCurrent Short Volume20,500 sharesPrevious Short Volume5,200 sharesChange Vs. Previous Month+294.23%Dollar Volume Sold Short$32,595.00Short Interest Ratio / Days to Cover0.5Last Record DateMarch 31, 2024Outstanding Shares17,240,000 sharesFloat Size7,980,000 sharesShort Percent of Float0.26%Today's Trading Volume2,609 sharesAverage Trading Volume39,034 sharesToday's Volume Vs. Average7% Short Selling Exagen ? Sign up to receive the latest short interest report for Exagen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXGN Short Interest Over TimeXGN Days to Cover Over TimeXGN Percentage of Float Shorted Over Time Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Exagen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202420,500 shares $32,595.00 +294.2%0.3%0.5 $1.59 3/15/20245,200 shares $8,424.00 +20.9%0.1%0.1 $1.62 2/29/20244,300 shares $9,675.00 -35.8%0.1%0.1 $2.25 2/15/20246,700 shares $14,137.00 -39.1%0.1%0.1 $2.11 1/31/202411,000 shares $23,650.00 +32.5%0.1%0.2 $2.15 1/15/20248,300 shares $16,600.00 -65.7%0.1%0.2 $2.00 Get the Latest News and Ratings for XGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exagen and its competitors with MarketBeat's FREE daily newsletter. 12/31/202324,200 shares $48,158.00 +633.3%0.3%0.5 $1.99 12/15/20233,300 shares $5,115.00 -65.6%0.0%0.1 $1.55 11/30/20239,600 shares $18,048.00 +28.0%0.1%0.3 $1.88 11/15/20237,500 shares $11,586.00 +4.2%0.1%0.4 $1.54 10/31/20237,200 shares $11,808.00 +24.1%0.1%0.6 $1.64 10/15/20235,800 shares $10,904.00 -45.3%0.1%0.4 $1.88 9/30/202310,600 shares $25,652.00 -14.5%0.1%0.7 $2.42 9/15/202312,400 shares $30,132.00 +27.8%0.2%0.8 $2.43 8/31/20239,700 shares $24,444.00 -17.8%0.1%0.6 $2.52 8/15/202311,800 shares $29,500.00 +81.5%0.1%0.8 $2.50 7/31/20236,500 shares $15,990.00 -38.7%0.1%0.3 $2.46 7/15/202310,600 shares $28,620.00 +39.5%0.1%0.6 $2.70 6/30/20237,600 shares $22,040.00 +8.6%0.1%0.5 $2.90 6/15/20237,000 shares $22,540.00 -42.2%0.1%0.4 $3.22 5/31/202312,100 shares $36,421.00 +72.9%0.1%0.6 $3.01 5/15/20237,000 shares $20,370.00 -54.6%0.1%0.3 $2.91 4/30/202315,400 shares $39,116.00 +75.0%0.2%0.9 $2.54 4/15/20238,800 shares $21,384.00 +8.6%0.1%0.5 $2.43 3/31/20238,100 shares $19,683.00 -16.5%0.1%0.4 $2.43 3/15/20239,700 shares $22,989.00 -54.9%0.1%0.4 $2.37 2/28/202321,500 shares $54,825.00 +32.7%0.2%0.8 $2.55 2/15/202316,200 shares $40,824.00 -22.1%0.2%0.3 $2.52 1/31/202320,800 shares $59,072.00 -64.0%0.2%0.2 $2.84 1/15/202357,800 shares $167,042.00 -20.4%0.6%0.6 $2.89 12/30/202272,600 shares $174,240.00 -30.1%0.7%0.8 $2.40 12/15/2022103,900 shares $257,672.00 +3.5%1.1%1.1 $2.48 11/30/2022100,400 shares $271,080.00 +666.4%1.0%1.1 $2.70 11/15/202213,100 shares $39,169.00 -34.8%0.1%0.2 $2.99 10/31/202220,100 shares $49,245.00 -33.7%0.2%0.7 $2.45 10/15/202230,300 shares $73,629.00 -14.2%0.3%1.6 $2.43 9/30/202235,300 shares $95,663.00 +18.5%0.4%1.6 $2.71 9/15/202229,800 shares $141,252.00 -18.4%0.3%0.7 $4.74 8/31/202236,500 shares $165,345.00 -5.7%0.4%0.8 $4.53 8/15/202238,700 shares $195,435.00 -14.8%0.4%0.7 $5.05At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… XGN Short Interest - Frequently Asked Questions What is Exagen's current short interest? Short interest is the volume of Exagen shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 20,500 shares of XGN short. 0.26% of Exagen's shares are currently sold short. Learn More on Exagen's current short interest. What is a good short interest percentage for Exagen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of Exagen's floating shares are currently sold short. Is Exagen's short interest increasing or decreasing? Exagen saw a increase in short interest in March. As of March 31st, there was short interest totaling 20,500 shares, an increase of 294.2% from the previous total of 5,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Exagen's float size? Exagen currently has issued a total of 17,240,000 shares. Some of Exagen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exagen currently has a public float of 7,980,000 shares. How does Exagen's short interest compare to its competitors? 0.26% of Exagen's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Exagen: DermTech, Inc. (10.31%), Centogene (0.10%), Psychemedics Co. (0.37%), BioNexus Gene Lab Corp. (0.61%), OpGen, Inc. (22.37%), Enzo Biochem, Inc. (2.04%), Personalis, Inc. (2.64%), Sensei Biotherapeutics, Inc. (0.96%), Inspira Technologies Oxy B.H.N. Ltd. (1.43%), DURECT Co. (3.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Exagen stock? Short selling XGN is an investing strategy that aims to generate trading profit from Exagen as its price is falling. XGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exagen? A short squeeze for Exagen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XGN, which in turn drives the price of the stock up even further. How often is Exagen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XGN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: DermTech Short Interest Centogene Short Interest Psychemedics Short Interest BioNexus Gene Lab Short Interest OpGen Short Interest Enzo Biochem Short Interest Personalis Short Interest Sensei Biotherapeutics Short Interest Inspira Technologies Oxy B.H.N. Short Interest DURECT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XGN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics